Orozco-Pérez J, Moreno-Flores M, Gutiérrez-Ureña JA, Sánchez-Zubieta F, Aguirre-Jáuregui OM, Soto-Blanquet JL, García-Martínez JA

Language: Spanish
References: 12
Page: 116-119
PDF size: 518.13 Kb.

ABSTRACT

Introduction: Permanent central venous catheters simplify the administration of cytotoxic drugs, blood derivatives, liquids, antibiotics and parenteral nutrition as well as sample taking in children with cancer. According with published medical literature worldwide, complication incidence can reach up to 22%. The goal of the present study is to describe the experience with the implementation of these devices in pediatric oncology patients.
Material and Methods: In a period of 12 months we documented the insertion and use of permanent central venous catheters in pediatric patients undergoing chemotherapy due to various malignant diseases, as well as results and complications associated with these devices.
Results: In total, a number of 65 patients with malignant disease were placed a permanent central venous catheter, 35 (59%) male patients and 30 female patients. Leukemia was the most frequent disease in 38 patients (59%). The modified Seldinger technique was the most performed in 45 patients (70%) and venous dissection in 20 (30%). In relation with the type of device used, the most frequently placed were: Port A Cath 57 (88%) and Hickman lines 8 (12%). The presented procedure complications were: hematomas 6 (9%), pneumothorax 1 (1.5%), hemothorax 1 (1.5%), infection 5 (8%) and catheter recue in one case. The most frequently isolated bacteria were Serratia spp and Proteus spp.
Discussion: Permanent catheters continue to play a key role in the treatment of pediatric oncology patients, as well as in the improvement of the children´s quality of life. There is no significant increase in morbidity or mortality of the base pathology with the use of these devices. Infection remains to be the biggest challenge, which is why caring for the caring for the keeping of the catheter is of great importance.

REFERENCES

1. Bartram, J.L., et al., Portacaths are safe for long-term regular blood transfusion in children with sickle cell anaemia. Arch Dis Child, 2011. 96(11): p. 1082-4.

2. Boussen, H., et al., [Epidemiological features and complications of central venous catheters in pediatric oncology: prospective study about 125 cases]. Arch Pediatr, 2006. 13(8): p. 1107-11.

3. Bass, J., et al., Central venous catheter database: an important issue in quality assurance. J Pediatr Surg, 2011. 46(5): p. 942-5.

4. Kim, J.T., et al., Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy. Med Oncol, 2012. 29(2): p. 1361-4.

5. Yeste Sanchez, L., et al., Protocol for the implantation of a venous access device (Port-A-Cath System). The complications and solutions found in 560 cases. Clin Transl Oncol, 2006. 8(10): p. 735-41.

6. Hancock-Howard, R., et al., Cost-effectiveness analysis of implantable venous access device insertion using interventional radiologic versus conventional operating room methods in pediatric patients with cancer. J Vasc Interv Radiol, 2010. 21(5): p. 677-84.

7. Handrup, M.M., et al., Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer, 2010. 55(2): p. 309-13.

8. Cecinati, V., et al., Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis, 2012. 31(11): p. 2869-77.

9. Schummer, W., et al., Mechanical complications and malpositions of central venous cannulations by experienced operators. A prospective study of 1794 catheterizations in critically ill patients. Intensive Care Med, 2007. 33(6): p. 1055-9.

10. Adwan, H., H. Gordon, and E. Nicholls, Are routine chest radiographs needed after fluoroscopically guided percutaneous insertion of central venous catheters in children? J Pediatr Surg, 2008. 43(2): p. 341-3.

11. Ribeiro, R.C., et al., Long-term complications in totally implantable venous access devices: randomized study comparing subclavian and internal jugular vein puncture. Pediatr Blood Cancer, 2012. 58(2): p. 274-7.

12. Sarper, N., et al., Totally implantable central venous access devices in children w th hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices. Pediatr Hematol Oncol, 2006. 23(6): p. 459-70.